TNF-alpha inhibitors associated with uveal melanoma
the ONA take:
According to new findings reported in the journal Mayo Clinic Proceedings, researchers warn that there may be a correlation between tumor necrosis factor (TNF)-alpha inhibitors and the development of uveal melanoma.
The researchers report three cases of uveal melanoma that occurred after patients were treated with TNF-alpha inhibitors. Two of the patients were treated at Mayo Clinic in Rochester, Minnesota, and the other was treated at Yale-New Haven Hospital in New Haven, Connecticut. All three, two women and one man, were treated for inflammatory disease with TNF-alpha inhibitors.
This class of drugs include adalimumab, certolizumab pegol, etanercept, golimumab, and infliximab, and they are used to treat inflammatory bowel disease, psoriasis, and rheumatoid arthritis. In the cases reported, the two women were treated for inflammatory bowel disease and developed rapidly growing melanocytic tumors within 1 year of TNF-alpha inhibitor initiation.
The male patient was treated for rheumatoid arthritis and developed a uveal melanoma within 16 months of TNF-alpha inhibitor therapy.
The researchers suggest that there is an association between TNF-alpha inhibitors and cutaneous melanoma and recommend that patients planning to initiate TNF-alpha inhibitor therapy have an eye exam before beginning therapy. If patients have preexisting nevi, they should be monitored with eye examinations at regular intervals during therapy.
There may be a correlation between TNF-alpha inhibitors and the development of uveal melanoma.
Sign Up for Free e-newsletters
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- A Witness to Letting Go: Nursing Care at the End of Life
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Age Not a Deterrent to Immunotherapy for Malignant Melanoma
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Modified XELIRI Noninferior to FOLFIRI for OS in Metastatic Colorectal Cancer
- Nabilone Improves Cancer-Associated Anorexia in Lung Cancer
- Direct-to-Consumer Genetic Test for Select BRCA Mutations Gets FDA Nod
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|